Equibles does not estimate personal net worth.
Get an email with a short summary when DBV Technologies S.A. publishes a filing, an earnings call transcript or a press release.
Get DBVT alertsKevin Malibiski has spoken on 1 earnings call across 1 company, most recently for DBV Technologies S.A. on October 28, 2026. DBV Technologies S.A. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at DBV Technologies S.A. includes Daniel Tassé (CEO and Board Member), Michel de Rosen (Chairman), Virginie Boucinha (CFO and Chief Accounting Officer) and 7 others.
“By way of a brief introduction, I've been in the pharmaceutical and biotech space for nearly 40 years, focusing my career on regulatory affairs and quality programs, as well as building and leading teams through innovative development and operations.”
Transcript header (unverified)
Biotechnology · Healthcare
